title: Corneal thickness values before and after oxybuprocaine 0.4% eye drops.
abstract: OBJECTIVE
  To determine changes in corneal thickness after topical anesthesia.
  
  
  METHODS
  Corneal thickness was measured before and 3 minutes after administration of two drops of oxybuprocaine 0.4% to 26 patients (26 eyes). We analyzed the corneal thickness of a control group, which was made up of 26 patients (26 eyes) before and 3 minutes after administration of two drops of saline solution. Corneal thickness was measured with the Orbscan Topography System II (Bausch Lomb Surg., Barcelona).
  
  
  RESULTS
  Variations higher than +/- 10 microm were found following the instillation of 2 oxybuprocaine eye drops in eight eyes (30.76%) at the inferonasal cornea, in six eyes (23.08%) at the superotemporal, temporal and inferotemporal cornea, in five eyes (19.23%) at the nasal cornea, in three eyes (11.53%) at the central cornea, and in two eyes (7.69%) at the superonasal cornea. Nevertheless, no significant differences in the mean corneal thickness at each corneal location between the first and the second corneal thickness measurements were found in anesthetized eyes.
  
  
  CONCLUSIONS
  Some individuals can present important increases and decreases in corneal thickness values after anesthetic eye drops. This effect of anesthetic eye drops must be considered by refractive surgeons when carrying out preoperative laser in situ keratomileusis corneal thickness measurements.
authors.affiliation: Department of Anesthesiology, Arnau de Vilanova Hospital, Valencia, Spain.
authors.forename: Isabel
authors.initials: I
authors.lastname: Asensio
authors.forename: Saleh M
authors.initials: SM
authors.lastname: Rahhal
authors.forename: Luis
authors.initials: L
authors.lastname: Alonso
authors.forename: José M
authors.initials: JM
authors.lastname: Palanca-Sanfrancisco
authors.forename: Juan A
authors.initials: JA
authors.lastname: Sanchis-Gimeno
mesh_terms: D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects*; D003315:Cornea / Q000187:drug effects* / Q000473:pathology*; D019781:Corneal Topography; D006801:Humans; D009883:Ophthalmic Solutions; D011343:Procaine / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000779:Anesthetics, Local; D009883:Ophthalmic Solutions; D012965:Sodium Chloride; D011343:Procaine; C005298:benoxinate